Kirsten Schroer - Concepedia

Author

Kirsten Schroer

Novartis (Switzerland)ORCID

Also Known As

K. Schroer, Kirsten Schroer

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)Forschungszentrum Jülich Novartis Institutes for BioMedical Research ZHAW Zurich University of Applied Sciences

About

Kirsten Schroer is an author at Novartis (Switzerland) specializing in biocatalysis, engineering, and biochemical engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	6	6	339
2	Medicine	3	3	158
3	Biochemistry	3	3	142
4	Biomolecular Engineering	3	3	81
5	Natural Sciences	2	2	92

Kirsten Schroer

Publications

645

Citations

H-Index

Page 1

	Year	Citations
High cell density cultivation of recombinant yeasts and bacteria under non-pressurized and pressurized conditions in stirred tank bioreactors Arnd Knoll, Stefan Bartsch, Bernward Husemann, Journal of Biotechnology BiomanufacturingEngineeringBiotechnologyBiochemical EngineeringPressurized Conditions	2007	94
Evolved Aliphatic Halogenases Enable Regiocomplementary C−H Functionalization of a Pharmaceutically Relevant Compound Takahiro Hayashi, Mathieu Ligibel, Emine Sager, Angewandte Chemie International Edition	2019	87
Engineering the Pichia pastoris methanol oxidation pathway for improved NADH regeneration during whole-cell biotransformation Kirsten Schroer, Klaus Peter Luef, Franz Stefan Hartner, Metabolic Engineering BiomanufacturingEngineeringBiotransformationBiochemistryNatural Sciences	2009	78
Absorption, Distribution, Metabolism, and Excretion of Capmatinib (INC280) in Healthy Male Volunteers and In Vitro Aldehyde Oxidase Phenotyping of the Major Metabolite Ulrike Glaenzel, Yi Jin, Regine Hansen, Drug Metabolism and Disposition	2020	68
Continuous asymmetric ketone reduction processes with recombinant Escherichia coli Kirsten Schroer, Ursula Mackfeld, I.A.W. Tan, Journal of Biotechnology BiomanufacturingEngineeringRecombinant Escherichia ColiBiochemical EngineeringBiotechnology	2007	60
Metabolism and Disposition of Siponimod, a Novel Selective S1P1/S1P5 Agonist, in Healthy Volunteers and In Vitro Identification of Human Cytochrome P450 Enzymes Involved in Its Oxidative Metabolism Ulrike Glaenzel, Yi Jin, Robert Nufer, Drug Metabolism and Disposition	2018	54
Enhancement of the NAD(P)(H) Pool in <i>Escherichia coli</i> for Biotransformation Florian Heuser, Kirsten Schroer, Stephan Lütz, Engineering in Life Sciences EngineeringEscherichia ColiMicrobial PhysiologyBiosynthesisIntracellular Nad	2007	50
Process Intensification for Substrate-Coupled Whole Cell Ketone Reduction by In Situ Acetone Removal Kirsten Schroer, Eva Tacha, Stephan Lütz Organic Process Research & Development Ionic LiquidChemical EngineeringBiomanufacturingEngineeringProcess Intensification	2007	39
Modulating Chemoselectivity in a Fe(II)/α-Ketoglutarate-Dependent Dioxygenase for the Oxidative Modification of a Nonproteinogenic Amino Acid Fabian Meyer, Raphael Frey, Mathieu Ligibel, ACS Catalysis	2021	36
Metabolomics for biotransformations: Intracellular redox cofactor analysis and enzyme kinetics offer insight into whole cell processes Kirsten Schroer, Bruno Zelić, Marco Oldiges, Biotechnology and Bioengineering	2009	22

Page 1